SCHEMBL26548166

SCHEMBL26548166

C[Si](C)(C)c1ccc(-c2ccc3cc(-c4ccc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)cc4)ccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 8/20 0.45
RXRB P28702 8/20 0.45
RXRG P48443 7/20 0.45
PGR P06401 1/20 0.40
S1PR1 P21453 3/20 0.39
S1PR3 Q99500 1/20 0.39
SCN5A Q14524 1/20 0.39
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
KIF11 P52732 1/20 0.37
NR1H4 Q96RI1 1/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
IDO1 P14902 1/20 0.35
TDO2 P48775 1/20 0.35
TEK Q02763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548160 1.00 RXRA (0.45) RXRARXRBRXRGPGRS1PR1
SCHEMBL26548546 1.00 RXRA (0.45) RXRARXRBRXRGPGRS1PR1
SCHEMBL26548684 0.95 RXRA (0.44) RXRARXRBRXRGPGRS1PR1
SCHEMBL26548675 0.95 RXRA (0.44) RXRARXRBRXRGPGRS1PR1
SCHEMBL26549021 0.95 RXRA (0.44) RXRARXRBRXRGPGRS1PR1
SCHEMBL26548153 0.89 KIF11 (0.48) PGRSCN5ANR1H2NR1H3KIF11
SCHEMBL26548148 0.89 KIF11 (0.48) PGRSCN5ANR1H2NR1H3KIF11
SCHEMBL26548527 0.89 KIF11 (0.48) PGRSCN5ANR1H2NR1H3KIF11
SCHEMBL26549932 0.87 RXRA (0.55) RXRARXRBRXRGPGRKIF11
SCHEMBL26548168 0.87 RXRA (0.55) RXRARXRBRXRGPGRKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 RXRA 4514/4885RXRB 4516/4885RXRG 4629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.